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Summary 
Olfactory ensheathing cells (OECs) are a unique glial population found in both the peripheral 
and central nervous system: they ensheath bundles of unmyelinated olfactory axons from 
their peripheral origin in the olfactory epithelium to their central synaptic targets in the 
glomerular layer of the olfactory bulb. Like all other peripheral glia (Schwann cells, satellite 
glia, enteric glia), OECs are derived from the embryonic neural crest. However, in contrast to 
Schwann cells, whose development has been extensively characterised, relatively little is 
known about their normal development in vivo. In the Schwann cell lineage, the transition 
from multipotent Schwann cell precursor to immature Schwann cell is promoted by canonical 
Notch signalling. Here, we present in situ hybridisation and immunohistochemistry data from 
chicken, mouse and human embryos that suggest a canonical Notch-mediated transition 




 Olfactory ensheathing cells (OECs) ensheath bundles of unmyelinated olfactory 
axons from their peripheral origin in the olfactory epithelium to their central synaptic targets 
in the glomerular layer of the olfactory bulb (reviewed by Ekberg et al., 2012). OECs are 
particularly attractive candidates for transplantation-mediated repair of the injured central 
nervous system (CNS): they not only promote axon growth, remyelinate axons, phagocytose 
debris and stimulate angiogenesis, but also (unlike Schwann cells, the glial cells of all other 
peripheral nerves) migrate into astrocyte-rich areas and do not induce the astrocyte stress 
response (reviewed by Roet and Verhaagen, 2014). They are also being investigated for 
peripheral nerve repair!(reviewed by Radtke and Kocsis, 2014). 
 Like Schwann cells and satellite glia (reviewed by Woodhoo and Sommer, 2008; 
Jacob, 2015; Jessen et al., 2015), OECs are derived from the neural crest (Barraud et al., 
2010). Hence, one possible future route for generating large numbers of patient-specific 
OECs for CNS repair would be to expand and differentiate the neural crest stem cells that 
persist in skin and hair follicles (Toma et al., 2001; Wong et al., 2006; Hunt et al., 2009; Hunt 
et al., 2010). Schwann cell development has been well characterised (reviewed by Woodhoo 
and Sommer, 2008; Jacob, 2015; Jessen et al., 2015), and myelinating Schwann cells have 
been generated in culture from adult skin-derived rodent and human neural crest stem cells 
(McKenzie et al., 2006; Sakaue and Sieber-Blum, 2015). In contrast, relatively little is known 
about the normal pathway of OEC differentiation, although there are many similarities with 
Schwann cell development. Characteristic Schwann cell lineage markers such as Ngfr 
(p75NTR, the low-affinity neurotrophin receptor), the early glial marker Fabp7 (Bfabp/Blbp; 
brain fatty acid-binding protein/brain lipid-binding protein) and Mpz (P0, myelin protein zero) 
have been identified in developing chicken and rodent OECs by immunostaining (Norgren et 
al., 1992; Kurtz et al., 1994; Drapkin and Silverman, 1999; Lee et al., 2001; Murdoch and 
Roskams, 2007; Barraud et al., 2010; Blanchart et al., 2011; Barraud et al., 2013; Pingault et 
al., 2013). The high mobility group domain transcription factor Sox10, which is required for 
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the formation of Schwann cells and satellite glia (Britsch et al., 2001; Paratore et al., 2001), 
is also expressed by developing OECs and required for their normal differentiation (Barraud 
et al., 2010; Barraud et al., 2013; Pingault et al., 2013). During Schwann cell and satellite 
glial cell development, Sox10 directly activates the Mpz promoter (Jacob et al., 2014; 
Peirano et al., 2000) by recruiting the histone deacetylases Hdac1 and Hdac2 (Jacob et al., 
2014). Sox10 also activates the Fabp7 promoter, but this is likely to be indirect (Jacob et al., 
2014) (reviewed by Jacob, 2015). 
 In spinal nerves, Schwann cell development involves the progression of neural crest-
derived cells through two transitional, antigenically distinct embryonic stages. The first is the 
formation of Fabp7-positive, Mpz-positive Schwann cell precursors (seen in mouse hindlimb 
nerves at embryonic day [E]12-13; in rat hindlimb nerves at E14-15) (Jessen et al., 1994; 
Dong et al., 1999). Schwann cell precursors require axon-derived Neuregulin1 type III for 
their survival (reviewed by Woodhoo and Sommer, 2008; Jessen et al., 2015). They are in 
fact multipotent progenitor cells, giving rise during normal development not only to Schwann 
cells, but also to endoneurial fibroblasts, melanocytes, parasympathetic neurons and 
odontoblasts (Joseph et al., 2004; Adameyko et al., 2009; Dyachuk et al., 2014; Espinosa-
Medina et al., 2014; Kaukua et al., 2014).  
 In Schwann cell development, the Schwann cell precursor stage is followed by the 
immature Schwann cell stage, characterised by up-regulation of glial fibrillary acidic protein 
(Gfap) and S100 calcium-binding protein beta (S100b) (generated in mouse hindlimb nerves 
during E13-15; in rat hindlimb nerves during E15-E17) (Dong et al., 1999; Jessen and 
Mirsky, 2005). Unlike Schwann cell precursors, immature Schwann cells can support their 
own survival via autocrine signalling (reviewed by Woodhoo and Sommer, 2008; Jessen et 
al., 2015). The formation of mature myelinating and non-myelinating Schwann cells occurs 
postnatally in rodents (reviewed by Jessen and Mirsky, 2005; Woodhoo and Sommer, 2008).  
 The transition from multipotent Schwann cell precursor to immature Schwann cell is 
promoted by canonical Notch signalling!(Woodhoo et al., 2009). In the canonical Notch 
pathway, the transmembrane ligand on a neighbouring cell interacts with the Notch receptor, 
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triggering two steps of proteolytic cleavage that release the Notch intracellular domain 
(NICD) from the membrane (reviewed by Andersson et al., 2011; Hori et al., 2013). The 
NICD translocates into the nucleus where it forms a transcriptional complex with the 
transcription factor Rbpj and the coactivator Maml1, triggering the expression of target 
genes including the Hairy and enhancer of split (Hes) family (reviewed by Kageyama et al., 
2007). Conditional Notch inactivation in Schwann cell precursors, using Desert hedgehog 
(Dhh) regulatory sequences to drive the Cre-mediated deletion of Rbpj or Notch1, delays the 
formation of immature Schwann cells (Woodhoo et al., 2009). Conversely, conditional Notch 
activation in Schwann cell precursors, using Dhh-Cre to drive NICD expression, accelerates 
the formation of immature Schwann cells (Woodhoo et al., 2009). 
 Here, we investigated whether Notch signalling might be similarly important during 
OEC development, by analysing the expression of multiple Notch pathway genes and 
activated Notch1 during chicken OEC development, and the expression of selected Notch 
pathway genes in mouse and human embryos. Our results suggest that there is a Notch-
mediated transition during OEC development, from an early Mpz-positive, 'OEC precursor' 
stage to a more mature stage that in chicken embryos expresses the Notch target gene 
Sox2.  
 
Materials and Methods 
 
Chicken and mouse embryo collection and sectioning 
 Fertilised chicken (Gallus gallus domesticus) eggs were obtained from commercial 
sources. Embryos were fixed in modified Carnoy's (6 volumes ethanol, 3 volumes 37% 
formaldehyde, 1 volume glacial acetic acid), dehydrated into ethanol, cleared in Histosol 
(National Diagnostics) and embedded in paraffin wax for sectioning at 6 µm on a rotary 
microtome (Microm). Wild-type mouse embryos were collected and immersion-fixed 
overnight in 4% paraformaldehyde in phosphate-buffered saline (PBS) at 4°C. Embryos 
were cryoprotected in sucrose, embedded in O.C.T. compound (Tissue Tek) and flash 
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frozen in isopentane on dry ice. 10 µm sections were taken on a rotary cryostat (Bright 
Instrument Company). 
 
Human foetal tissue collection, sectioning and cDNA synthesis 
 Ethical approval for the use of postmortem human foetal nasal tissue was given by 
the National Research Ethics Service Committee East of England - Cambridge Central, UK. 
The tissue was collected at Addenbrooke’s Hospital (Cambridge, UK) from patients who had 
requested pregnancy terminations, and dissected at the John van Geest Centre for Brain 
Repair, University of Cambridge, Cambridge, UK. Tissue comprising the cartilage of the 
nasal septum, the medial zygomatic region, the maxillae of the developing upper jaw, and 
the base of the orbital cavities was dissected in HIBERNATE media (Gibco) from the facial 
region of 7-8-week embryos.  
 For cryosectioning, the tissue was immersion-fixed overnight in 4% 
paraformaldehyde in PBS at 4°C, then cryoprotected in 30% diethylpyrocarbonate-treated 
sucrose, embedded in O.C.T. compound (Tissue Tek), flash frozen in isopentane on dry ice 
and stored at -80°C. 10 µm sections were taken on a rotary cryostat (Bright Instrument 
Company).  
 For cDNA synthesis, the tissue was transferred to the lysis buffer from the Arcturus 
PicoPure RNA extraction kit (ThermoFisher Scientific), and then to Trizol (Invitrogen) for 
homogenisation and total RNA extraction according to the manufacturer's instructions. 
Single-strand cDNA was generated using Invitrogen’s Superscript III First-Strand Synthesis 
System kit. 
 
In situ hybridisation 
 Chicken Hes4 (Hairy1), Jag1, Jag2, Notch1 and Lfng were kind gifts of Nicolas 
Daudet (University College London, UK). Fragments of mouse Jag1, Jag2 and Notch1 and 
of human Jag1 and Notch1 were cloned by PCR (Table 1) from, respectively, embryonic day 
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(E)12.5 mouse cDNA (kind gift of Perrine Barraud, Dept. Physiology, Development and 
Neuroscience, University of Cambridge, UK) and cDNA prepared from 7-week-old dissected 
human foetal facial region (see previous section). Primer-BLAST software from NCBI!(Ye et 
al., 2012) was used to design appropriate PCR primers (Table 1) and check them for 
specificity. The oligonucleotide properties calculator program OligoCalc (Kibbe, 2007) 
(http://www.basic.northwestern.edu/biotools/oligocalc.html) was used to check the melting 
temperature and self-complementarity of the primers. cDNA fragments were amplified by 
PCR and the products cloned into pDrive (Qiagen) using the Qiagen PCR cloning kit. 
Sequencing was performed by the Biochemistry Department DNA Sequencing Facility, 
University of Cambridge (Cambridge, UK). Digoxigenin-labelled antisense riboprobes were 
generated using standard methods (Henrique et al., 1995) and in situ hybridisation 
performed on cryosections as previously described (O'Neill et al., 2007) except that the 
slides were not treated with proteinase K. 
 
Immunohistochemistry 
 Immunohistochemistry was performed as previously described (Lassiter et al., 2007), 
except that primary and secondary antibody solutions contained 10% heat-inactivated sheep 
or donkey serum for blocking. Primary antibodies used were: anti-Elavl3/4 (HuC/D) (mouse 
IgG2b, Invitrogen; 1:500); anti-FABP7 (BLBP) (rabbit, Merck Millipore ABN14; 1:1000), anti-
activated Notch1 (rabbit, Abcam ab8925; 1:150); anti-SOX2 (goat, Santa Cruz 
Biotechnology, Inc., sc-17320, 1:500; rabbit, Abcam ab92494; 1:300); anti-Sox10 (rabbit, gift 
from Vivian Lee, Medical College of Wisconsin, USA; 1:1000); anti-Tubb3 (clone TUJ1, 
mouse IgG2a, Covance; 1:500). Appropriately matched Alexa Fluor 488-, 568- or 594-
conjugated secondary antibodies, Alexa Fluor 350-NeutrAvidin and Alexa Fluor 488-
streptavidin were obtained from Molecular Probes/Invitrogen, and biotinylated secondary 




Notch1 is up-regulated in developing chicken OECs from embryonic day 5.5 
 The earliest stage at which developing chicken OECs have been detected is 
embryonic day (E)3.5, when myelin protein zero (Mpz, P0) expression is first seen on the 
olfactory nerve, roughly 12 hours after the first olfactory axons emerge from the olfactory 
epithelium at E3 (Drapkin and Silverman, 1999). At E4.5, in situ hybridisation on sections 
revealed faint Notch1 expression in the apical olfactory epithelium, but no detectable above-
background expression in cells on the olfactory nerve (Fig. 1A-B1). These cells include 
Elavl3/4 (HuC/D)-positive gonadotropin-releasing hormone (GnRH) neurons migrating away 
from the olfactory epithelium (reviewed by Wray, 2010) (also see Sabado et al., 2012), as!
well as developing OECs.  
 By E5.5, Notch1 expression is detected in a few Sox10-positive developing OECs 
associated with olfactory axons (black/white arrowheads), as well as being strong in the 
olfactory epithelium and around blood vessels (yellow arrowheads) (Fig. 1C-D1). At E6.5, 
three days after Mpz-positive developing OECs are first detected on the olfactory nerve 
(Drapkin and Silverman, 1999), Notch1 is expressed by many non-neuronal (Elavl3/4-
negative) cells associated with olfactory axons, presumably OECs (Fig. 1E-F1). Notch1 is 
also expressed by presumptive Schwann cell precursors on adjacent trigeminal nerve 
branches, and by cells associated with the walls of the developing vasculature (yellow 
arrowheads) (Fig. 1E-F1). At E9.5, Notch1 is expressed by Sox10-positive OECs in the 
olfactory nerve layer surrounding the olfactory bulb (black/white arrowheads), and also by 
cells associated with microvasculature within the olfactory nerve layer (yellow arrowheads) 
(Fig. 1G-G3). At E10.5, Notch1 is still expressed strongly on the olfactory nerve by Sox10-
positive OECs (black/white arrowheads) and by Sox10-negative cells in larger gaps between 
olfactory axon bundles, most likely associated with endoneurial vasculature (yellow 
arrowheads) (Fig. 1H-I3). At the same stage, Notch1 is expressed by many Sox10-positive 
Schwann cells on the oculomotor nerve (black/white arrowheads) and also by Sox10-
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negative cells in gaps between axon bundles, presumably around the endoneurial 
vasculature (yellow arrowheads) (Fig. 1J-J3). 
 The up-regulation of Notch1 expression in the OEC lineage from E5.5, two days after 
Mpz-positive glial cells are first detected on the olfactory nerve at E3.5 (Drapkin and 
Silverman, 1999), is reminiscent of the increased expression of Notch1 mRNA detected by 
RT-PCR on embryonic rat hindlimb nerves between E14 (Schwann cell precursor stage) and 
E18 (immature Schwann cell stage) (Woodhoo et al., 2009). This suggests the possibility 
that Notch signalling may drive a comparable step in OEC maturation from an early 'OEC 
precursor' stage characterised by expression of Mpz (Norgren et al., 1992; Drapkin and 
Silverman, 1999). 
 
Notch1 signalling is active in developing chicken OECs 
 In the rat, increased NICD expression is detected by Western blot between E14 
(when Schwann cell precursors are present) and E18 (when immature Schwann cells are 
present) (Woodhoo et al., 2009). Immunostaining sections with an antibody against activated 
Notch1, which detects the N-terminal sequence of the cleaved human NICD, suggested that 
the Notch pathway is active in at least some OECs (located between Tubb3-positive axon 
bundles) on the chicken olfactory nerve at E8.5 (Fig. 2A-B1).  
 Further support for active Notch signalling in a subset of chicken OECs is provided 
by Notch target gene expression in cells on the olfactory nerve and in the olfactory nerve 
layer of the olfactory bulb. Chicken Hes4 is a homologue of Drosophila hairy, originally 
named cHairy1 (Palmeirim et al., 1997). In humans, HES4 (which is missing in rodents) is 
the most similar of the seven HES family proteins to HES1, which is encoded by a direct 
Notch target gene involved in maintaining certain stem and progenitor cells (Kobayashi and 
Kageyama, 2014). At E9.5, chicken Hes4 is expressed by a subset of developing OECs and 
Schwann cells (black/white arrowheads, Fig. 2C-E3). This could be the result of oscillatory 
expression, as seen for Hes1 (Hirata et al., 2002). Hes4 is also expressed by Sox10-
negative cells on both the olfactory nerve and other peripheral nerves (yellow arrowheads, 
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Fig. 2C-E3): these may be associated with the endoneurial vasculature, given that Hes4 is 
also expressed by cells in the walls of nearby blood vessels (yellow arrows, Fig. 2D-D3). 
 Lunatic fringe (Lfng) is another Notch target gene, encoding a glycosyltransferase 
that regulates Notch pathway activity via glycosylation of the Notch receptor in the Golgi 
apparatus (reviewed by Takeuchi and Haltiwanger, 2014). In situ hybridisation for Lfng on 
the olfactory nerve at E10.5 (Fig. 2F-G3) reveals a more sparse expression pattern than 
Notch1 (compare with Fig. 1I-I3, which shows a nearby section from the same embryo). 
Indeed, Lfng is expressed by only a subset of Sox10-positive OECs (black/white 
arrowheads, Fig. 2G-G3) (and is also expressed by Sox10-negative cells in larger gaps 
between Tubb3-positive olfactory axon bundles, presumably around developing blood 
vessel; yellow arrowheads, Fig. 2G-G3). Lfng transcripts can also be detected at E10.5 in 
Sox10-positive Schwann cells on the oculomotor nerve (black/white arrowheads, Fig. 2H-H3) 
(and in Sox10-negative cells in gaps between axon bundles, presumably around the 
endoneurial vasculature; yellow arrowheads, Fig. 2H-H3).  
 Overall, these results suggest that the Notch signalling pathway is active during 
chicken OEC development, most likely from the first up-regulation of Notch1 in developing 
OECs from E5.5, with activity maintained in a subset of OECs until at least E10.5. 
 
Notch1 signalling in developing chicken OECs may up-regulate Sox2 
 Transfection of an activated form of chicken Notch1 into cultured chicken neural crest 
cells promotes expression of the high mobility group (HMG) domain transcription factor Sox2 
(Wakamatsu et al., 2004) (indeed Sox2 is a direct target of Notch/Rbpj signalling in mouse 
neural stem cells; Ehm et al., 2010; Li et al., 2012). Sox2 is expressed by Schwann cell 
precursors and immature Schwann cells in both chicken and mouse, but its down-regulation 
is necessary for Schwann cell maturation and myelination (Wakamatsu et al., 2004; Le et al., 
2005; Adameyko et al., 2012), although weak Sox2 expression is maintained in non-
myelinating Schwann cells!(Koike et al., 2014). These results prompted us to investigate 
Sox2 expression during OEC development.  
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 At E5.5 (when only a few developing OECs express Notch1; Fig. 1C-D1), 
immunostaining revealed no Sox2 expression on the olfactory nerve (Fig. 3A-B2), although 
faint expression was seen in Schwann cell precursors on the trigeminal nerve (arrowheads, 
Fig. 3B-B2). A day later, at E6.5 (Fig. 3C-D2), Sox2 is expressed by almost all Sox10-positive 
developing OECs on the olfactory nerve, as well as the Sox10-positive Schwann cells on the 
adjacent trigeminal nerve (arrowheads, Fig. 3D-D2). At E7.5 (Fig. 3E-G2), Sox2 expression is 
maintained in Sox10-positive developing OECs (arrowheads, Fig. 3F-F2), as well as in 
developing Schwann cells on an adjacent tissue section (arrowheads, Fig. 3G-G2). At E10.5 
(Fig. 3H-J1), Sox2 is expressed by non-neuronal cells on the olfactory nerve, presumably 
OECs (Fig. 3I,I1), and also in Schwann cells (Fig. 3J,J1). At E13.5 (Fig. 3K-M1) (several days 
after the onset of synapse formation between olfactory receptor neurons and their targets in 
the olfactory bulb, which occurs at E8-10; Ayer-Le Lièvre et al., 1995), Sox2 is still 
expressed by OECs on the olfactory nerve (Fig. 3L,L1), but seems to have been down-
regulated in the Schwann cell lineage (Fig. 3M,M1) (presumably during the transition from 
immature to mature Schwann cells; Le et al., 2005).  
 Overall, these results suggest that in chicken embryos, Notch1 signalling may 
mediate a transition from a Sox2-negative OEC precursor stage to a more mature Sox2-
positive OEC stage.  
 
Chicken olfactory receptor neurons express the Notch ligand genes Jag1 and Jag2 
 In the rat, the canonical Notch ligand Jagged1 (Jag1) is expressed on sciatic nerve 
axons at E14, suggesting this could be involved in Notch signalling during the transition from 
Schwann cell precursor to immature Schwann cell (Woodhoo et al., 2009). In the chick at 
E6.0, Jag1 is expressed by Elavl3/4-positive olfactory receptor neurons in the olfactory 
epithelium (black/white arrowheads), as well as in non-neuronal support cells (yellow 
arrowheads) (Fig. 4A-B4). At E6.5, Jag2 expression is similarly expressed in Elavl3/4-
positive olfactory receptor neurons in the olfactory epithelium (black/white arrowheads), as 
well as in non-neuronal support cells (yellow arrowheads), but is also detected in migratory 
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Elavl3/4-positive neurons on the olfactory nerve (white arrows) (Fig. 4C-D4). Jag2 
expression is maintained in olfactory receptor neurons in the intermediate layer of the 
olfactory epithelium (Beites et al., 2005) until at least E8.5 (Fig. 4E-F1). Since both Jag1 and 
Jag2 are expressed by embryonic chicken olfactory receptor neurons at the stage when 
Notch1 is up-regulated in developing OECs, these ligands could be available on olfactory 
axons to activate Notch1 signalling in adjacent glial cells. 
 
Embryonic mouse and human OECs express Notch1, while olfactory receptor 
neurons express Jag1/2  
 In the mouse, Notch1 is expressed by OECs on the olfactory nerve and in the 
olfactory nerve layer of the olfactory bulb at both E14.5 and E16.5 (Fig. 5A-D1).  
 A complementary expression pattern for Jag1 and Jag2 was previously reported in 
the mouse olfactory epithelium at E12.5, with Jag1 mostly confined to apical cells, and Jag2 
expressed weakly in apical cells and more strongly in intermediate and basal progenitors 
(Cau et al., 2002). We found a similar complementary expression pattern at both E14.5 and 
E16.5. At E14.5, Jag1 is expressed apically in the olfactory epithelium, presumably by 
sustentacular cells, and by at least some olfactory receptor neurons in the intermediate layer 
(indeed, Jag1 mRNA seems to be present within olfactory axons themselves) (Fig. 5E-F1). 
By E16.5, however, Jag1 expression is restricted to the non-neuronal apical layer of the 
olfactory epithelium (Fig. 5G-H1), where sustentacular cells are located (Beites et al., 2005). 
In contrast, Jag2 is strongly expressed by Tubb3-positive olfactory receptor neurons in the 
intermediate layer at both E14.5 and E16.5 (Jag2 mRNA also seemed to be present in 
olfactory axons), but is more weakly expressed by the apical layer of sustentacular cells 
(Fig. 5I-L1). Thus, Jag1 and Jag2 are expressed by olfactory receptor neurons at E14.5, with 
Jag2 (though not Jag1) expression maintained until at least E16.5. Hence, these ligands 
could be available on olfactory axons to activate Notch1 in developing mouse OECs. 
 We also identified Notch1 expression in cells on the human olfactory nerve at both 7 
weeks (roughly Carnegie stage 20, when the olfactory bulb is forming; Bossy, 1980) and 8 
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weeks of development (Carnegie stage 23, after the olfactory bulb has formed; Bossy, 
1980). The Notch1-positive cells are presumably OECs since Notch1 expression does not 
overlap with migratory Elavl3/4-positive neurons (Fig. 6A-D1). At 8 weeks of development, 
the Notch ligand gene Jag1 is expressed in the intermediate and basal layers of the olfactory 
epithelium, suggesting expression in both olfactory receptor neurons (black/white 
arrowheads) and basal progenitors and/or the precursors of emigrating neurons (black/white 
arrows), which also seem to express Jag1 (Fig. 6E-G3). Furthermore Jag1 is detected in 
non-neuronal mesenchymal cells of the lamina propria surrounding the emerging olfactory 
axons (yellow arrows, Fig. 6E-G3), which could be another source of Notch pathway 
activation in developing OECs. 
 
Embryonic mouse and human OECs do not express the Notch target Sox2 
 In E16.5 mouse embryos, Sox2 is expressed by immature Schwann cells on 
trigeminal nerves as expected (Fig. 7A-B1), but in striking contrast to chicken embryos, we 
could not detect Sox2 expression in OECs, whether on the olfactory nerve or in the olfactory 
nerve layer of the olfactory bulb (Fig. 7C-D1). Similarly, in human embryos at both 7 and 8 
weeks of development, Sox2 is expressed by developing Schwann cells on peripheral 




 Our investigation of Notch signalling pathway gene expression in developing OECs 
arose from its importance for Schwann cell development (Woodhoo et al., 2009). Activating 
Notch signalling in Schwann cell precursors (which can be distinguished from their neural 
crest precursors by expression of Mpz and Fabp7, amongst others; Woodhoo and Sommer, 
2008; Jacob, 2015; Jessen et al., 2015) accelerated the formation of immature Schwann 
cells, while blocking Notch signalling in Schwann cell precursors delayed the formation of 
immature Schwann cells (Woodhoo et al., 2009). PCR of rat sciatic nerves showed that the 
receptor genes Notch1-3 are all up-regulated from E14 to E18, coinciding with the transition 
from Schwann cell precursors to immature Schwann cells (Woodhoo et al., 2009). We found 
that Notch1 is similarly up-regulated in developing chicken OECs starting with a few cells at 
E5.5, two days after the first Mpz-positive cells can be identified on the developing olfactory 
nerve at E3.5 (Drapkin and Silverman, 1999). Canonical Notch activity is maintained in at 
least a subset of OECs until E10.5, as the cleaved Notch1 intracellular domain can be 
identified at E8.5, and expression of the Notch target genes Hes4 and Lfng is also seen in 
subsets of developing OECs at E9.5 and E10.5, respectively. We also identified Notch1 
expression in mouse OECs at E14.5 and E16.5, and in human OECs at 7 and 8 weeks of 
development. In immature Schwann cells, Notch signalling actively inhibits myelination and 
thus must be down-regulated for the terminal differentiation of myelinating Schwann cells 
(Woodhoo et al., 2009). PCR of non-myelinating Schwann cells at postnatal day 5 in the 
mouse has identified the maintenance of Notch receptor and target gene expression, in 
contrast to myelinating Schwann cells from the same stage (Woodhoo et al., 2009). Since 
OECs are non-myelinating in their normal environment, it is likely that they also maintain 
Notch signalling into postnatal development, and down-regulation of this pathway is likely to 
be required for their ability to myelinate larger-diameter axons both in vitro and in vivo, for 
example when transplanted into at sites of CNS damage (reviewed by Roet and Verhaagen, 
2014). 
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 We also identified up-regulation of the Notch/Rbpj target gene Sox2 (Wakamatsu et 
al., 2004; Ehm et al., 2010) in the chicken OEC lineage from E6.5. Sox2 is expressed during 
Schwann cell precursor and immature Schwann cell stages, but down-regulation is 
necessary for Schwann cell maturation and myelination (Wakamatsu et al., 2004; Le et al., 
2005; Adameyko et al., 2012) (weak Sox2 expression is maintained in non-myelinating 
Schwann cells;!Koike et al., 2014). Sox2 is thought to play a key role in maintaining the 
Schwann cell precursor/immature Schwann cell state since cross-regulatory suppression by 
the transcription factors Egr2 (Krox20) and Mitf result in Sox2 downregulation and 
commitment to, respectively, a myelinating Schwann cell (Egr2-positive) fate or a 
melanocyte (Mitf-positive) fate (Adameyko et al., 2012). Our results suggest that during OEC 
development in the chicken embryo, canonical Notch signalling mediates a transition from 
an early Mpz-positive, Sox2-negative 'OEC precursor' stage to a more mature Sox2-positive 
stage. Sox2 is maintained in chicken OECs until at least E13.5: since this is several days 
after olfactory receptor neurons have begun to form synapses with their targets in the 
olfactory bulb, at E8-10 (Ayer-Le Lièvre et al., 1995), OECs might be expected to be 
phenotypically mature by this stage. In the Schwann cell lineage, Sox2 already seems to 
have been down-regulated by E13.5, presumably during the transition from immature to 
mature Schwann cells (Le et al., 2005). However, this seems not to be conserved in 
mammals, since we were unable to detect Sox2 expression in either mouse or human 
OECs, although it was present in developing Schwann cells.  
 Finally, we found that olfactory receptor neurons in chicken, mouse and human 
embryos express the canonical Notch ligand gene Jag1 at stages when Notch1 is detected 
in developing OECs. (In chicken and mouse embryos, we also identified expression of Jag2 
in olfactory receptor neurons.) Similarly, Jag1 protein (detected by immunostaining) is 
expressed on sciatic nerve axons at E14 and at birth in the rat (although it is also present on 
Schwann cell precursors and Schwann cells) (Woodhoo et al., 2009). Thus, it is tempting to 
speculate that one or both of these ligands are available on olfactory axons to activate 
Notch1 in developing OECs and promote their maturation.   
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 Overall, our data support a role for a transition in OEC development from an early 
Mpz-positive 'OEC precursor' to a more mature stage, mediated by canonical Notch1 
signalling and potentially activated by Jag1 from adjacent olfactory axons. A deeper 
molecular understanding of normal OEC development is important not only for our 
understanding of how neural crest cells generate different glial subtypes (reviewed by Jacob, 
2015), but also since it may be possible in the future to expand and differentiate the neural 
crest stem cells that persist in skin and hair follicles (Toma et al., 2001; Wong et al., 2006; 
Hunt et al., 2009; Hunt et al., 2010) into patient-specific OECs for CNS repair. 
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Gene NCBI reference 
sequence 




NM_013822.5 CCAGTGTCAGAATGACGCCT TCGACATGTACCCCCGTAGT 1631 -2312 
Mouse 
Jag2 
NM_010588.2 AACGGTGGCACATGCTATGA ATTCCAGAGCAGATAGCGCC 2178-3001 
Mouse 
Notch1 
NM_008714.3 TTGACGTCACTCTCCTGTGC AAGTGCGGGCATCATTCTCA 3593 - 4318 
Human 
Jag1 
NM_000214.2 TCACGGGAAGTGCAAGAGTC CCCATGGTGATGCAAGGTCT 2319 - 3116 
Human 
Notch1 
NM_017617.3 GGGTACAAGTGCGACTGTGA TGACATCGTGCTGGCAGTAG 2206 - 3067 
 
Table 1. PCR cloning information for mouse and human Notch pathway cDNA fragments.  
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Fig. 1 Notch1 is upregulated in developing chicken OECs from E5.5 
Parasagittal (A-D1) and coronal (E-K3) sections of the embryonic chicken olfactory system. 
(A) At E4.5, Notch1 expression is seen in the eye and brain. (B) Higher-power view of boxed 
region in A, showing Notch1 expression in the apical olfactory epithelium, but no convincing 
above-background expression on the olfactory nerve. (B1) Same section as B 
immunostained for Tubb3-positive axons and Elavl3/4-positive neuronal cell bodies, with a 
false-colour overlay of Notch1. (C-D1) At E5.5, Notch1 is expressed in a few Sox10-positive 
developing OECs (black/white arrowheads) and also around developing blood vessels 
(yellow arrowheads). (E-F1) At E6.5, Notch1 is expressed by non-neuronal (Elavl3/4-
negative) cells on the olfactory nerve, presumably developing OECs, and by Schwann cell 
precursors on the adjacent trigeminal nerve. Notch1 is also expressed by cells in the walls of 
nearby blood vessels (yellow arrowheads). (G-G3) At E9.5, Notch1 is expressed by Sox10-
positive OECs in the olfactory nerve layer surrounding the olfactory bulb (black/white 
arrowheads), and also in cells associated with small blood vessels within the olfactory nerve 
layer (yellow arrowheads). (H-I3) At E10.5, immunostaining for Sox10 confirms that Notch1 is 
expressed by OECs on the olfactory nerve (black/white arrowheads highlight examples). 
Notch1 is also expressed by Sox10-negative cells located in the larger gaps between the 
Tubb3-positive axon bundles (yellow arrowheads), potentially in the walls of the 
microvasculature of the olfactory nerve. (J-J3) Also at E10.5 (on the same section as H-I3), 
Notch1 expression is seen in many Sox10-positive Schwann cells on the oculomotor nerve 
(black/white arrowheads highlight examples), and also in Sox10-negative cells in gaps 
between axon bundles (yellow arrowheads), presumably in the walls of the endoneurial 
vasculature. BV, blood vessel; Elav, Elavl3/4; FB, forebrain; OB, olfactory bulb; OCN, 
oculomotor nerve; OE, olfactory epithelium; ON, olfactory nerve. Scale bar: 100 µm.   
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Fig. 2 Notch signalling is active in developing chicken OECs 
Coronal sections of the embryonic chicken olfactory system. (A-B1) At E8.5, immunostaining 
for Tubb3 and activated (cleaved) Notch1 reveals the presence of activated Notch1 in many 
cells between the Tubb3-positive axon bundles of the olfactory nerve, presumably 
developing OECs. (C-D3) At E9.5, the Notch target gene Hes4 (Hairy1) is expressed by a 
subset of Sox10-positive OECs on the olfactory nerve (black/white arrowheads). Hes4 is 
also expressed by Sox10-negative cells in the larger gaps between the Tubb3-positive axon 
bundles (yellow arrowheads); these may be associated with endoneurial microvasculature, 
given that Hes4 is also expressed by cells in the walls of blood vessels (yellow arrowheads 
highlight examples). (E-E3) Also at E9.5 (on the same section as C-D3), Hes4 is expressed 
by a subset of Sox10-positive Schwann cells on the oculomotor nerve (black/white 
arrowheads), in addition to Sox10-negative cells (yellow arrowheads). (F-G3) At E10.5, the 
Notch target gene Lfng is expressed by a subset of Sox10-positive OECs on the olfactory 
nerve (black/white arrowheads). Lfng is also expressed by Sox10-negative cells in the larger 
gaps between the Tubb3-positive axon bundles (yellow arrowheads), potentially associated 
with blood vessels. (H-H3) On the same section, Lfng is expressed by a subpopulation of 
Sox10-positive Schwann cells on the oculomotor nerve (black/white arrowheads), and by 
Sox10-negative cells, potentially associated with endoneurial microvasculature (yellow 
arrowheads). OCN, oculomotor nerve; ON, olfactory nerve. Scale bar: 100 µm.  
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Fig. 3 The Notch target Sox2 is upregulated in chicken OECs from E6.5 and 
maintained until at least E13.5  
Parasagittal (A-G2) and coronal (H-M1) sections of the embryonic chicken olfactory system. 
(A-B2) At E5.5, immunostaining for Sox2, Tubb3-positive axons and Sox10-positive OECs 
reveals absence of Sox2 on the olfactory nerve (B,B1), although in a different region of the 
same section, weak Sox2 expression is detected in Schwann cell precursors on the 
trigeminal nerve (arrowheads, B-B2). (C-D2) At E6.5, Sox2 is detected in almost all Sox10-
positive developing OECs on the olfactory nerve, as well as in Sox10-positive Schwann cells 
on the trigeminal nerve (arrowheads, D-D2). (E-G2) At E7.5, Sox2 expression is maintained 
in Sox10-positive developing OECs (arrowheads, F-F2). Insets in F-F2 show Sox2 expression 
in Sox10-positive Schwann cells on the trigeminal nerve from an adjacent tissue section 
(arrowheads, G-G2). (H-J1) At E10.5, Sox2 is expressed by non-neuronal cells on the 
olfactory nerve, presumably OECs (I,I1), and in Schwann cells on a nearby peripheral nerve 
in the same section (J,J1). (K-M1) At E13.5, Sox2 expression is maintained in non-neuronal 
cells between the bundles of olfactory axons, presumably OECs (L,L1), but Sox2 is no longer 
expressed by Schwann cells on a nearby peripheral nerve in the same section (M,M1). Elav, 
Elavl3/4; FB, forebrain; OB, olfactory bulb; OCN, oculomotor nerve; OE, olfactory epithelium; 
ON, olfactory nerve; ONL, olfactory nerve layer; PN, peripheral nerve; TN, trigeminal nerve. 
Scale bar: 100 µm.   
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Fig. 4 The canonical Notch ligand genes Jag1 and Jag2 are expressed by chicken 
olfactory receptor neurons  
Parasagittal sections of the embryonic chicken olfactory system. (A,B) At E6.0, Jag1 is 
expressed throughout the olfactory epithelium. (B1-B4) Same section as B immunostained for 
Tubb3-positive axons and Elavl3/4-positive neuronal cell bodies, with a false-colour overlay 
of Jag1, reveals that Jag1 is expressed by Elavl3/4-positive olfactory receptor neurons 
(black/white arrowheads) and also non-neuronal supporting cells (yellow arrowheads). (C-
D4) At E6.5, Jag2 is expressed by Elavl3/4-positive olfactory receptor neurons in the 
intermediate layer (black/white arrowheads), by a few Elavl3/4-negative apical support cells 
(yellow arrowheads), and by migrating Elavl3/4-positive neurons on the olfactory nerve 
(black/white arrows). Jag2 expression can also be seen in the vasculature, most likely in 
endothelial cells. (E-F1) At E8.5, Jag2 expression is maintained in olfactory receptor neurons 
in the intermediate layer of the olfactory epithelium. Expression is also seen in the 
vasculature, most likely endothelial cells. Elav, Elavl3/4; FB, forebrain; OE, olfactory 
epithelium; ON, olfactory nerve. Scale bar: 100 µm.  
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Fig. 5 Notch1 is expressed by embryonic mouse OECs, while Jag1 and Jag2 are 
expressed by olfactory receptor neurons 
Sections of the embryonic olfactory system in mouse (E14.5 parasagittal; E16.5 coronal). (A) 
In E14.5 mouse embryos, Notch1 is expressed by the basal layer of the olfactory epithelium 
and in the subventricular zone of the forebrain. (B) Higher-power view of boxed region in A, 
showing expression of Notch1 in the olfactory nerve layer around the olfactory bulb. (B1) 
Same section as B immunostained for Tubb3-positive axons, with a false-colour overlay of 
Notch1. (C-D1) At E16.5, Notch1 is expressed by OECs on the olfactory nerve and in the 
olfactory nerve layer of the olfactory bulb. (E-F1) At E14.5, Jag1 is expressed by Tubb3-
positive olfactory receptor neurons and their axons (black/white arrowheads), in non-
neuronal apical support cells in the olfactory epithelium (yellow arrowheads), and in non-
neuronal cells close to the olfactory epithelium, likely mesenchymal cells of the lamina 
propria (black/white arrows). (G-H1) By E16.5, Jag1 expression is restricted to apical 
(sustentacular) cells in the olfactory epithelium and to non-neuronal cells apposed to the 
olfactory epithelium and near, but not directly associated with, Tubb3-positive olfactory 
axons (most likely mesenchymal cells of the lamina propria, arrows). (NB Expression around 
the olfactory bulbs, seen at low-power in panel G, is not within the olfactory nerve layer but 
deep to it.) (I-J1) At E14.5, Jag2 is expressed by all cells in the olfactory epithelium, though 
more weakly in the most apical cells (arrowheads, J,J1). Jag2 expression can also be 
detected in olfactory axons (arrows). In contrast to Jag1, Jag2 is not expressed by 
mesenchymal cells in the lamina propria (compare with F,F1). (K-L1) By E16.5, expression of 
Jag2 is essentially reciprocal to Jag1: it remains strong in olfactory receptor neurons in the 
intermediate layer, and in basal progenitors, but is more weakly expressed by the most 
apical layer. No expression is seen in mesenchymal cells in the lamina propria (compare 
with H,H1). (NB Expression around the olfactory bulbs, seen at low-power in panel K, is not 
within the olfactory nerve layer but deep to it.) FB, forebrain; OB, olfactory bulb; OE, 
olfactory epithelium; ON, olfactory nerve. Scale bar: 100 µm. 
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Fig. 6 Notch1 is expressed by embryonic human OECs, while Jag1 is expressed by 
olfactory receptor neurons 
Parasagittal sections of the human embryonic olfactory system. (A) At 7 weeks of 
development, Notch1 is expressed by the subventricular zone of the forebrain. (A1) Same 
section as A showing Tubb3 immunostaining for axons. (B) Higher-power view of boxed 
region in A, showing expression of Notch1 on the olfactory nerve. (B1) Same section as B 
immunostained for Tubb3-positive axons and Elavl3/4-positive neurons, with a false-colour 
overlay of Notch1, shows that Notch1 is expressed by non-neuronal cells on the olfactory 
nerve, presumably developing OECs. (C-D1) At 8 weeks, Notch1 is expressed by non-
neuronal cells on the olfactory nerve, presumably developing OECs. (E-F1) At 8 weeks of 
development, Jag1 can be detected in Elavl3/4-positive olfactory receptor neurons in the 
intermediate and basal layers of the olfactory epithelium (white arrowheads), which might be 
newly differentiated olfactory receptor neurons and/or precursors of the Jag1-positive 
migratory neurons on the olfactory nerve (white arrows). Jag1 expression is also seen in 
non-neuronal mesenchymal cells in the lamina propria (yellow arrows). BV, blood vessel; 
FB, forebrain; OB, olfactory bulb; OE, olfactory epithelium; ON, olfactory nerve. Scale bar: 
100 µm.   
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Fig. 7 Embryonic human and mouse OECs do not express the Schwann cell precursor 
and immature Schwann cell marker Sox2 
Coronal sections of the embryonic mouse (A-D1) and human (E-L) olfactory systems. (A) At 
E16.5 in the mouse, immunostaining for Tubb3-positive axons provides an overview of the 
olfactory system. (B,B1) Higher-power view of boxed region in A, showing Sox2 expression 
in cells associated with Tubb3-positive trigeminal axons, presumably developing Schwann 
cells. (C-D1) In contrast, on the same section shown in A-B1, Sox2 is not expressed by 
OECs in the olfactory nerve layer of the olfactory bulb, or on the olfactory nerve. (E-F1) At 7 
weeks of human development, SOX2 is strongly expressed by cells on the TUBB3-positive 
trigeminal nerve, presumably developing Schwann cells, but (G-H1) SOX2 is not expressed 
by developing OECs on the olfactory nerve. (I-J1) Similarly at 8 weeks of human 
development, SOX2 is detected in developing Schwann cells but (K-L1) is absent or 
expressed at very low levels in OECs on the same section. FB, forebrain; OB, olfactory bulb; 
OE, olfactory epithelium; ON, olfactory nerve; ONL, olfactory nerve layer; PN, peripheral 
nerve; TN, trigeminal nerve. Scale bar: 100 µm. 







